Muhd Najmi Hakim Abdul Rani

Mr. Muhd Najmi Hakim Abdul Rani

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 July 2026 in Journal of Cardiothoracic Surgery
Verified
Journal Article
Open access
PDF file
Muhd Najmi Hakim Abdul RaniMuhd Najmi Hakim Abdul Rani
Muhd Najmi Hakim Abdul Rani
AMAfifah Mohamed
Afifah Mohamed
ZIZaleha Md Isa
Zaleha Md Isa
SKSuhaini Kadiman
Suhaini Kadiman
TKTaty Anna Kamarudin
Taty Anna Kamarudin
Background: Infective endocarditis (IE) carries in-hospital mortality of 15–20% and 1-year mortality approaching 40%, with surgery required in 40–50% of cases. IE is not uniformly distributed across cardiac valves aortic 30–45%, mitral 25–30%, tricuspid 5–10%, pulmonary < 2%, PVE 10–30% and this distribution reflects valve-specific anatomical determinants governing surgical complexity and outcomes. Despite the 2023 ESC Guidelines, a unified structural framework linking anatomical vulnerability to surgical decision-making remains absent. Objective: To propose a valve-specific structural vulnerability framework and examine its implications for surgical complexity, perioperative outcomes, and re-surgery risk across all cardiac valve types. Methods: A narrative review of peer-reviewed literature (2015–2025) was conducted across PubMed, Scopus, and MEDLINE. Systematic reviews, meta-analyses, multicentre registries, and guideline documents were synthesised narratively. Key Findings: A structural vulnerability gradient (prosthetic valves > aortic > mitral > tricuspid > pulmonary) is proposed as a conceptual model of valve-specific disease behaviour. Aortic IE carries maximal vulnerability through peri-annular extension, 30–40% of cases, requiring radical root reconstruction with elevated operative mortality. Mitral IE exhibits conditional vulnerability; repair yields superior outcomes over replacement. Tricuspid IE is predominantly IVDU-associated with comparatively lower operative mortality. PVE carries the highest operative risk, with prolonged operative times and significant reoperation rates. Conclusions: IE is best understood as a valve- and substrate-specific disease in which anatomical determinants drive surgical complexity and clinical prognosis. This proposed vulnerability hierarchy may enable preoperative risk stratification, inform valve-specific surgical planning, and provide a mechanistic framework for understanding differential outcomes across valve types. Prospective outcome registries and standardised complexity metrics are needed to validate and refine this conceptual model.

13 August 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Muhd Najmi Hakim Abdul RaniMuhd Najmi Hakim Abdul Rani
Muhd Najmi Hakim Abdul Rani
AMAfifah Mohamed
Afifah Mohamed
ZIZaleha Md Isa
Zaleha Md Isa
Suhaini KadimanSuhaini Kadiman
Suhaini Kadiman
TKTaty Anna Kamarudin
Taty Anna Kamarudin
Background/Objectives: Infective endocarditis (IE) is a life-threatening cardiovascular infection with in-hospital mortality of 15–30% despite modern therapy. Contemporary IE demonstrates non-random valve involvement: aortic and mitral 35–45%, tricuspid 5–10% (30–50% in intravenous drug users [IVDU]), and pulmonary < 1%. These patterns implicate valve-specific anatomy and hemodynamics as central determinants of susceptibility. This narrative review examines the reported distribution of IE across the aortic, mitral, tricuspid and pulmonary valves and summarises the anatomical, haemodynamic, structural, microbial and patient-related factors associated with valve-specific susceptibility. Methods: A structured narrative review of English-language literature was conducted using PubMed/MEDLINE, Embase, Scopus, and Google Scholar (January 1990–March 2026). Search terms included “infective endocarditis,” “valve anatomy,” “hemodynamics,” “bicuspid aortic valve,” “prosthetic valve endocarditis,” and “transcatheter aortic valve replacement (TAVR) endocarditis.” We included anatomical studies, clinical cohorts, surgical series, imaging research, and international guidelines. Evidence was synthesized narratively using Oxford Centre for Evidence-Based Medicine (CEBM) levels. Results: IE susceptibility follows a biologically coherent gradient determined by the interaction between valve anatomy, hemodynamic stress, endothelial injury, and structural substrate. The aortic valve is most vulnerable because of high shear stress, congenital abnormalities such as bicuspid aortic valve, and direct continuity with the cardiac fibrous skeleton, predisposing to peri-annular extension. Mitral valve IE is largely conditional upon pre-existing structural disease, particularly mitral valve prolapse, rheumatic heart disease, and mitral annular calcification, and is characterized by a high risk of systemic embolization. Tricuspid valve IE reflects the interaction between low-pressure hemodynamics and acquired patient-specific modifiers, including intravenous drug use, cardiovascular implantable electronic devices, and congenital heart disease. Pulmonary valve IE remains uncommon because of favorable native hemodynamics but occurs predominantly in repaired congenital heart disease, right ventricular outflow tract reconstruction, and prosthetic pulmonary valves. Across all valve types, multimodality imaging and anatomical assessment consistently influence complication detection, surgical planning, and long-term surveillance. Conclusions: IE involvement is unevenly distributed among the cardiac valves. Aortic and mitral involvement predominate, tricuspid involvement is strongly influenced by injection drug use and intracardiac devices, and pulmonary-valve IE remains rare and is principally associated with congenital abnormalities or prosthetic material. These patterns highlight the possible contributions of haemodynamic stress, pre-existing structural abnormalities, and age-related valvular changes to the greater susceptibility of left-sided valves.

8 June 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
Muhd Najmi Hakim Abdul RaniMuhd Najmi Hakim Abdul Rani
Muhd Najmi Hakim Abdul Rani
AMAfifah Mohamed
Afifah Mohamed
ZIZaleha Md Isa
Zaleha Md Isa
Suhaini KadimanSuhaini Kadiman
Suhaini Kadiman
TKTaty Anna Kamarudin
Taty Anna Kamarudin
Background: Infective endocarditis (IE) is a life-threatening cardiovascular infection with in-hospital mortality of 15–30% despite modern therapy. Contemporary IE demonstrates non-random valve involvement: aortic 40–60%, mitral 20–40%, tricuspid 5–10% (30–50% in intravenous drug users [IVDU]), and pulmonary < 1%. These patterns implicate valve-specific anatomy and hemodynamics as central determinants of susceptibility. Methods: Structured narrative review of English-language literature from PubMed/MEDLINE, Embase, Scopus, and Google Scholar (January 1990–March 2026). Search terms included “infective endocarditis,” “valve anatomy,” “hemodynamics,” “bicuspid aortic valve,” “prosthetic valve endocarditis,” and “TAVR endocarditis.” We included anatomical studies, clinical cohorts, surgical series, imaging research, and international guidelines. Evidence was synthesized narratively using Oxford CEBM levels. Results: IE susceptibility follows a biologically coherent gradient shaped by hemodynamic stress, endothelial injury, and structural substrate. The aortic valve (40–60% of native IE) is most vulnerable due to high shear stress, frequent congenital anomalies (bicuspid aortic valve [BAV]: 2% prevalence, 24% of aortic IE), and direct fibrous skeleton continuity—predisposing to periannular extension (30–40%). Mitral IE (20–40%) is largely conditional on structural disease (mitral valve prolapse [MVP]: 8-fold risk increase; embolic rates 30–50%). Tricuspid IE (5–10%; 30–50% in IVDU) reflects low-pressure hemodynamics with lower mortality (10–20%) but high recurrence (15–30%). Pulmonary IE (< 1%) is rare due to minimal hemodynamic stress. Prosthetic valves carry 0.3–6% annual IE risk; TAVR-specific risks include paravalvular regurgitation and residual native tissue. Conclusions: IE susceptibility is fundamentally determined by valve-specific anatomy interacting with hemodynamic forces and microbial virulence. This anatomy-informed framework guides risk stratification and identifies prevention targets.